Activation of Checkpoint Kinase 2 (Chk2) Contributes to the Antitumour Synergy between Igf1 Receptor Kinase Inhibitor Nvp-Aew541 and Sunitinib in Hepatocellular Carcinoma

腫瘤醫學研究所OU, DA-LIANGDA-LIANGOUSHEN, YING-CHUNYING-CHUNSHENHSU, CHIUNCHIUNHSUCHENG, ANN-LIIANN-LIICHENG2012-07-122018-07-092012-07-122018-07-092011http://ntur.lib.ntu.edu.tw//handle/246246/241804en-USActivation of Checkpoint Kinase 2 (Chk2) Contributes to the Antitumour Synergy between Igf1 Receptor Kinase Inhibitor Nvp-Aew541 and Sunitinib in Hepatocellular Carcinoma